One in Five US Orphan Drug Designations This Month Goes to Korean Firms
Three of 14 therapeutics designated as US FDA orphan drugs this month were developed by Korean firms Yuhan, ABL Bio, and Xcellomol, boosting technology export prospects.
Briefing on user experience design trends, UX research developments, and product design best practices. For product and design teams.
Curated AI briefing - Updates with new content
Create your own AI-powered briefing on any topic — delivered automatically.
You might also enjoy these briefings
Briefing on financial regulations, banking compliance news, and fintech...
Track product launches, feature releases, and product strategy news across...
US-Israel Operation Epic Fury strikes on Iran, Khamenei assassination
Follow corporate governance news, regulatory filings, and business law...
Enjoyed this briefing? Get it delivered to your inbox!
Create Free Account